Europe Drug Discovery Market 2019-2028

MARKET OUTLOOK

As per this report, the drug discovery market in the European region is expected to show commendable growth in terms of revenue during the forecasting years 2019-2028, with a CAGR of 6.21%.
The UK, France, Italy, Spain, Germany, Russia, and the Rest of Europe together make the market for drug discovery in this region.

Germany is home to several biotech and pharma companies working on both small and large molecules. Bayer, Boehringer Ingelheim, Schering Pharma, Abbott, Roche, and Merck are some of the major players operating in the country. These players are developing innovative technologies to boost the drug discovery processes in the country. This is majorly expected to drive the growth of the German drug discovery market in the forecasting period.

The adoption of innovative techniques for drug discovery, along with collaborations between organizations, is primarily fueling the growth of the studied market in France. For instance, the country is expanding its partnership with India in areas of research relating to medicinal chemistry and chemical technology. Further, according to government data, there are more than 20,000 clinical studies going on in the country for the discovery and development of new drugs. In November 2018, Sanofi announced that it would be funding 19 innovative research projects. The increasing funding and collaborations between various government & private entities are expected to boost the overall growth of the French drug discovery market over the forecast period.

COMPETITIVE OUTLOOK

The prime companies in the drug discovery market are AstraZeneca Plc, Eli Lily and Company, Antares Pharma Inc, Boehringer Ingelheim, Johnson & Johnson, Bayer AG, Agilent Technologies Inc, and 3M Company.

1. Europe Drug Discovery Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threats of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Covid-19 and Its Impact on Drug Discovery Market
2.4. PESTLE Outlook
2.5. Regulatory Framework
2.6. Value Chain Outlook
2.7. Market Attractiveness Index
2.8. Key Insight
2.9. Market Drivers
2.9.1. Growing Aged Population
2.9.2. Technological Advancements
2.9.3. Rise in Healthcare Expenditure
2.9.4. Surge in Lifestyle-Oriented Diseases
2.10. Market Restraints
2.10.1. Delay in Product Launches
2.10.2. Restricted Growth Rate Due to Generic Drugs
2.11. Market Opportunities
2.11.1. Significant Investment by Healthcare Industries in Improving Big Data Analytical Capabilities
2.11.2. Rising Demand for Specialty Medicines
2.12. Market Challenges
2.12.1. Stringent Government Regulations

3. Drug Discovery Market Outlook - by Drug Type

3.1. Small Molecule Drug
3.2. Biologic Drug

4. Drug Discovery Market Outlook - by Technology

4.1. High Throughput Screening
4.2. Biochips
4.3. Bioinformatics
4.4. Pharmacogenomics and Pharmacogenetics
4.5. Combinatorial Chemistry
4.6. Nanotechnology
4.7. Spectroscopy
4.8. Metabolomics
4.9. Other Technologies

5. Drug Discovery Market Outlook - by Service

5.1. Drug Metabolism and Pharmacokinetics (Dmpk) Services
5.2. Chemical Services
5.3. Biological Services
5.4. Other Pharmaceutical Services

6. Drug Discovery Industry Outlook - by End-User

6.1. Research Institutes
6.2. Pharmaceutical Companies
6.3. Contract Research Organizations (Cros)
6.4. Other End-Users

7. Drug Discover Market – Europe

7.1. Country Analysis
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Italy
7.1.6. Russia
7.1.7. Rest of Europe

8. Company Profiles

8.1. 3M Company
8.2. Abbott Laboratories Inc
8.3. Agilent Technologies Inc
8.4. Antares Pharma Inc
8.5. Astrazeneca plc
8.6. Bayer AG
8.7. Becton Dickinson & Company (Bd)
8.8. Boehringer Ingelheim
8.9. Eli Lily and Company
8.10. F Hoffmann-La Roche Ltd
8.11. GlaxoSmithKline LLC
8.12. Johnson & Johnson
8.13. Merck & Co Inc
8.14. Novartis
8.15. Pfizer Inc
8.16. Sanofi

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1 Europe Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 2 Europe Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 3 Europe Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 4 Europe Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 5 Europe Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 6 Europe Drug Discovery Market, by Country, 2019-2028 ($ Million)

List of Figures

Figure 1 Europe Drug Discovery Market, by Region, 2019-2028 ($ Million)
Figure 2 Europe Drug Discovery Market, by Small Molecule Drug, 2019-2028 ($ Million)
Figure 3 Europe Drug Discovery Market, by Biologic Drug, 2019-2028 ($ Million)
Figure 4 Europe Drug Discovery Market, by High Throughput Screening, 2019-2028 ($ Million)
Figure 5 Europe Drug Discovery Market, by Biochips, 2019-2028 ($ Million)
Figure 6 Europe Drug Discovery Market, by Bioinformatics, 2019-2028 ($ Million)
Figure 7 Europe Drug Discovery Market, by Pharmacogenomics and Pharmacogenetics, 2019-2028 ($ Million)
Figure 8 Europe Drug Discovery Market, by Combinatorial Chemistry, 2019-2028 ($ Million)
Figure 9 Europe Drug Discovery Market, by Nanotechnology, 2019-2028 ($ Million)
Figure 10 Europe Drug Discovery Market, by Spectroscopy, 2019-2028 ($ Million)
Figure 11 Europe Drug Discovery Market, by Metabolomics, 2019-2028 ($ Million)
Figure 12 Europe Drug Discovery Market, by Other Technologies, 2019-2028 ($ Million)
Figure 13 Europe Drug Discovery Market, by Drug Metabolism and Pharmacokinetics (Dmpk) Services, 2019-2028 ($ Million)
Figure 14 Europe Drug Discovery Market, by Chemical Services, 2019-2028 ($ Million)
Figure 15 Europe Drug Discovery Market, by Biological Services, 2019-2028 ($ Million)
Figure 16 Europe Drug Discovery Market, by Other Pharmaceutical Services, 2019-2028 ($ Million)
Figure 17 Europe Drug Discovery Market, by Research Institutes, 2019-2028 ($ Million)
Figure 18 Europe Drug Discovery Market, by Pharmaceutical Companies, 2019-2028 ($ Million)
Figure 19 Europe Drug Discovery Market, by Contract Research Organizations (Cros), 2019-2028 ($ Million)
Figure 20 Europe Drug Discovery Market, by Other End-Users, 2019-2028 ($ Million)
Figure 21 the United Kingdom Drug Discovery Market 2019-2028 ($ Million)
Figure 22 France Drug Discovery Market 2019-2028 ($ Million)
Figure 23 Germany Drug Discovery Market 2019-2028 ($ Million)
Figure 24 Spain Drug Discovery Market 2019-2028 ($ Million)
Figure 25 Italy Drug Discovery Market 2019-2028 ($ Million)
Figure 26 Russia Drug Discovery Market 2019-2028 ($ Million)
Figure 27 Rest of Europe Drug Discovery Market 2019-2028 ($ Million)